C. Lorrie Epling

654 total citations
9 papers, 295 citations indexed

About

C. Lorrie Epling is a scholar working on Epidemiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Lorrie Epling has authored 9 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Lorrie Epling's work include Cytomegalovirus and herpesvirus research (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Herpesvirus Infections and Treatments (3 papers). C. Lorrie Epling is often cited by papers focused on Cytomegalovirus and herpesvirus research (4 papers), Sarcoma Diagnosis and Treatment (3 papers) and Herpesvirus Infections and Treatments (3 papers). C. Lorrie Epling collaborates with scholars based in United States, Australia and Canada. C. Lorrie Epling's co-authors include Elizabeth Sinclair, Mark Z. Jacobson, Douglas Black, Barry M. Bredt, Alexander Carvidi, Katherine K. Matthay, Steven G. DuBois, Juli Teague, Frederick Hecht and Steven G. Deeks and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Infectious Diseases.

In The Last Decade

C. Lorrie Epling

9 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Lorrie Epling United States 8 99 92 57 55 50 9 295
Nutthapong Tangsinmankong United States 10 106 1.1× 154 1.7× 38 0.7× 38 0.7× 28 0.6× 19 296
Maria Inês de Moura Campos Pardini Brazil 13 113 1.1× 66 0.7× 19 0.3× 65 1.2× 45 0.9× 42 374
Chike O. Abana United States 11 74 0.7× 135 1.5× 109 1.9× 56 1.0× 47 0.9× 17 339
Shay Leary Australia 10 57 0.6× 117 1.3× 78 1.4× 96 1.7× 30 0.6× 26 304
Melinda Lowe Australia 9 80 0.8× 154 1.7× 119 2.1× 45 0.8× 37 0.7× 15 366
J L Sullivan United States 6 56 0.6× 90 1.0× 22 0.4× 87 1.6× 77 1.5× 6 338
S. Erb Canada 10 136 1.4× 64 0.7× 32 0.6× 57 1.0× 62 1.2× 14 361
Laura A. Vella United States 12 97 1.0× 329 3.6× 64 1.1× 98 1.8× 37 0.7× 19 609
H.W. Pees Germany 10 79 0.8× 164 1.8× 55 1.0× 38 0.7× 37 0.7× 30 387
Luis A. Correa Colombia 10 151 1.5× 125 1.4× 37 0.6× 23 0.4× 8 0.2× 24 396

Countries citing papers authored by C. Lorrie Epling

Since Specialization
Citations

This map shows the geographic impact of C. Lorrie Epling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lorrie Epling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lorrie Epling more than expected).

Fields of papers citing papers by C. Lorrie Epling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lorrie Epling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lorrie Epling. The network helps show where C. Lorrie Epling may publish in the future.

Co-authorship network of co-authors of C. Lorrie Epling

This figure shows the co-authorship network connecting the top 25 collaborators of C. Lorrie Epling. A scholar is included among the top collaborators of C. Lorrie Epling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Lorrie Epling. C. Lorrie Epling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Anderson, Jenny L., Gabriela Khoury, Rémi Fromentin, et al.. (2019). Human Immunodeficiency Virus (HIV)–Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy. The Journal of Infectious Diseases. 221(5). 744–755. 37 indexed citations
2.
Vo, Kieuhoa T., C. Lorrie Epling, Elizabeth Sinclair, et al.. (2016). Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clinical Cancer Research. 22(14). 3643–3650. 17 indexed citations
3.
DuBois, Steven G., C. Lorrie Epling, Alice J. Tan, Katherine K. Matthay, & Elizabeth Sinclair. (2012). Flow cytometric quantification of surface IGF-1R and intracellular p-AKT, p-S6, and p-ERK in Ewing sarcoma (EWS) cells.. Journal of Clinical Oncology. 30(30_suppl). 23–23. 1 indexed citations
4.
DuBois, Steven G., C. Lorrie Epling, Juli Teague, Katherine K. Matthay, & Elizabeth Sinclair. (2009). Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow. Pediatric Blood & Cancer. 54(1). 13–18. 41 indexed citations
5.
Owen, Rachel E., Elizabeth Sinclair, Brinda Emu, et al.. (2007). Loss of T cell responses following long-term cryopreservation. Journal of Immunological Methods. 326(1-2). 93–115. 75 indexed citations
6.
Jacobson, Mark Z., Elizabeth Sinclair, Barry M. Bredt, et al.. (2006). Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients. Journal of Clinical Virology. 35(3). 332–337. 30 indexed citations
7.
Jacobson, Mark Z., Elizabeth Sinclair, Barry M. Bredt, et al.. (2006). Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12. Vaccine. 24(25). 5311–5319. 32 indexed citations
8.
Sinclair, Elizabeth, Douglas Black, C. Lorrie Epling, et al.. (2004). CMV Antigen-Specific CD4 + and CD8 + T Cell IFNγ Expression and Proliferation Responses in Healthy CMV-Seropositive Individuals. Viral Immunology. 17(3). 445–454. 30 indexed citations
9.
Epling, C. Lorrie, et al.. (1992). Neutrophil function screenlng in patients with chronic granulomatous disease by a flow cytometric method. Cytometry. 13(6). 615–620. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026